Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis (Q65387133)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis |
clinical trial |
Statements
A Multicenter, Randomized, Double-blind Placebo-controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Moderately to Severely Active Ulcerative Colitis (English)
0 references
November 2006
0 references
April 2009
0 references
576
0 references
18 year
0 references